The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease

被引:41
作者
Beck, M [1 ]
机构
[1] Univ Mainz, Childrens Hosp, D-6500 Mainz, Germany
关键词
Fabry disease; MSSI;
D O I
10.1080/08035320600618825
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Fabry disease is a rare lysosomal storage disorder caused by the deficient activity of the lysosomal enzyme a-galactosidase A. The resultant storage of undegraded glycolipids leads to the progressive development of potentially life-threatening manifestations affecting multiple organ systems in the body. This paper describes the development of the Mainz Severity Score Index (MSSI), a scoring system for patients with Fabry disease. Conclusion: The MSSI score has been proven to be representative in patients with 'classic' Fabry disease and may be useful for monitoring clinical improvement in patients receiving enzyme replacement therapy.
引用
收藏
页码:43 / 46
页数:4
相关论文
共 5 条
  • [1] Desnick RobertJ., 2001, The Metabolic and Molecular Bases of Inherited Disease, V8th, P3733, DOI DOI 10.1036/ommbid.181
  • [2] The use of scoring systems in patients with haematological malignancy
    Hughes, Derralynn A.
    [J]. ACTA PAEDIATRICA, 2006, 95 : 47 - 51
  • [3] Prevalence of lysosomal storage disorders
    Meikle, PJ
    Hopwood, JJ
    Clague, AE
    Carey, WF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (03): : 249 - 254
  • [4] The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents
    Ries, M
    Ramaswami, U
    Parini, R
    Lindblad, B
    Whybra, C
    Willers, I
    Gal, A
    Beck, M
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2003, 162 (11) : 767 - 772
  • [5] The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy
    Whybra, C
    Kampmann, C
    Krummenauer, F
    Ries, M
    Mengel, E
    Miebach, E
    Baehner, F
    Kim, K
    Bajbouj, M
    Schwarting, A
    Gal, A
    Beck, M
    [J]. CLINICAL GENETICS, 2004, 65 (04) : 299 - 307